A Virginia family has won $4.02 million in a pharmaceutical injury lawsuit involving the drug Topamax. According to Bloomberg News, jurors deliberated for less than an hour before reaching the…
Read More
Pharmaceutical giant Glaxo Smith Klyne (GSK) has begun a new test study of its controversial antidepressant Paxil using a group of 7-year-old Japanese children as the subjects. GSK officials confirmed…
Read More
I’ve been writing a lot lately, as a pharmaceutical injury attorney, about lawsuits against Pfizer for its role in making and selling Reglan. So I was interested to see another…
Read More
According to the Yaz Resource Center, a patient advocacy group, sufferers of Yaz and Yasmin side effects may be more likely to receive settlements from the makers of the pills,…
Read More
With all of the Levaquin lawsuits waiting to go on trial over the severe side effects of the popular antibiotic, patients may be ready to consider talking to their doctors…
Read More
FDA Warns Public to avoid 69 Brands of Dangerous Diet Pills — Missouri Defective Medication Attorney
The U.S. Food and Drug Administration has warned consumers not to use any of 69 defective over-the-counter diet drugs, USA Today reported Jan. 7. The drugs covered by the warning…
Read More
An Actos lawsuit has now been filed by a major insurance company. The insurer, Blue Cross and Blue Shield of Massachusetts, is seeking to obtain damages that were allegedly incurred as…
Read More
According to information from a new study, there may be a link between depression and temporomandibular joint (TMJ) disorder. TMJ is a condition that affects the muscles and joints that…
Read More
As a pharmaceutical liability attorney, I’m very interested in the ongoing litigation over injuries allegedly caused by the antibiotic Levaquin (levofloxacin). Levaquin is part of a class of antibiotics called…
Read More
The drug Mirapex is prescribed for treatment of Parkinson’s disease, but it has an unusual but frightening unexpected side effect: compulsive gambling. This drug has not been getting the same…
Read More